Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why developing new antibiotics is a losing battle

Christopher Johnson, MD
Meds
October 29, 2019
12 Shares
Share
Tweet
Share

“We believe that the current entrepreneurial development model for antibiotics is broken and needs to be fundamentally transformed.”

This provocative opinion is from a recent editorial in the New England Journal of Medicine. The introduction of penicillin, the first antibiotic miracle drug, led to an 80 percent reduction in mortality from infectious diseases. Other antibiotics quickly followed, reducing death rates even further. Over the past several decades, however, the discovery of new antibiotics has greatly slowed; most are what are called “me too” drugs that are potentially profitable for the manufacturer but not in any way ground-breaking. Emerging resistance to antibiotics was noted soon after their discovery, but newer agents appeared to keep us one step ahead of the pathogens. This breathing room may now have disappeared — we now are confronted with pathogenic bacteria that are completely resistant to all known antibiotics. Some have termed our new situation the post-antibiotic era. So we desperately need newer agents to treat infection. Where are these to come from?

The editorial writers describe how ineffectual our current model is for developing these essential new antibiotics. For one thing, development costs are enormous — up to two billion dollars. There is also this problem:

Rising rates of resistance appear to create new market opportunities for antibiotics. However, the absolute number of infections caused by each type of resistant bacterium is relatively small. Each newly approved antibiotic thus captures an ever-shrinking share of an increasingly splintered market — a problem that will only worsen over time.

A widely influential solution was proposed by the economist Jim O’Neill in 2016. His idea was to offer a variety of special financial incentives to drug companies to develop new antibiotics. Now he says it’s simply time to “just take it away from them and take it over.” The authors of The New England Journal editorial propose a model consisting of nonprofit organizations to focus on all aspects of preventing infections — not just new antibiotics but also things like vaccines, immunotherapies, and inflammatory modulators. I agree such a multifaceted approach is important because resistance among bacteria will always be an issue. A key principle here is using multiple approaches that work in different ways. We certainly use that principle in infectious disease practice by combining antibiotics that work in different ways.

Establishing new ways of organizing our fight against infection would be difficult. But market-based, for-profit approaches simply haven’t worked at all. Drug companies are actually losing money trying. And thus as a society, we’re losing the battle.

Christopher Johnson is a pediatric intensive care physician and author of Keeping Your Kids Out of the Emergency Room: A Guide to Childhood Injuries and Illnesses, Your Critically Ill Child: Life and Death Choices Parents Must Face, How to Talk to Your Child’s Doctor: A Handbook for Parents, and How Your Child Heals: An Inside Look At Common Childhood Ailments. He blogs at his self-titled site, Christopher Johnson, MD.

Image credit: Shutterstock.com

Prev

Why your doctor may be concerned about prescribing benzodiazepines

October 29, 2019 Kevin 4
…
Next

This pediatrician gives her kids candy on Halloween. Here are 7 guilt-free candy tips.

October 30, 2019 Kevin 1
…

Tagged as: Infectious Disease

Post navigation

< Previous Post
Why your doctor may be concerned about prescribing benzodiazepines
Next Post >
This pediatrician gives her kids candy on Halloween. Here are 7 guilt-free candy tips.

More by Christopher Johnson, MD

  • The success of Australian firearms regulation: What it could mean for children

    Christopher Johnson, MD
  • Do protocols and pathways improve care?

    Christopher Johnson, MD
  • Why are so many community hospitals transferring children to larger facilities?

    Christopher Johnson, MD

Related Posts

  • Why you should think twice about prescribing antibiotics

    Rich Rodriguez, MD
  • Should only infectious disease specialists be allowed to prescribe antibiotics?

    Craig Bowron, MD
  • Losing my first patient

    Allie Poles
  • Inappropriate antibiotics are the new drugs of abuse

    Rosemary Eseh-Logue, MD
  • What the FDA forgets in the battle against e-cigarettes

    Charlene Gaw
  • Losing a patient in an emergency

    Ton La, Jr., MD, JD

More in Meds

  • Counterfeit drugs: a hidden danger lurking in your medicine cabinet

    Emily Kahoud
  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • Most Popular

  • Past Week

    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Collaborating with occupational therapists: a game-changer for behavioral health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
  • Recent Posts

    • Collaborating with occupational therapists: a game-changer for behavioral health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Breaking the cycle of failure in modern medicine

      Kortney West, MD | Physician
    • ChatGPT: the Napster of the AI world?

      Harvey Castro, MD, MBA | Tech
    • The missing piece of physicians’ financial plans

      Daniel B. Wrenne, CFP | Finance
    • Counterfeit drugs: a hidden danger lurking in your medicine cabinet

      Emily Kahoud | Meds
    • How understanding cultural backgrounds can lead to better patient care [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Is Surgery Riskier After a COVID Infection?
  • The Best Medicine for Healthcare Workers: A Living Wage
  • Meat Consumption and UTIs; Air Pollution's Effects on Health
  • 'Early Birds' With Sleep Apnea May Get More CPAP Benefits
  • Mental Health Care Goes Beyond Just the Patient

Meeting Coverage

  • VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy
  • Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups
  • Oral Roflumilast Effective in the Treatment of Plaque Psoriasis
  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Most Popular

  • Past Week

    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Collaborating with occupational therapists: a game-changer for behavioral health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
  • Recent Posts

    • Collaborating with occupational therapists: a game-changer for behavioral health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Breaking the cycle of failure in modern medicine

      Kortney West, MD | Physician
    • ChatGPT: the Napster of the AI world?

      Harvey Castro, MD, MBA | Tech
    • The missing piece of physicians’ financial plans

      Daniel B. Wrenne, CFP | Finance
    • Counterfeit drugs: a hidden danger lurking in your medicine cabinet

      Emily Kahoud | Meds
    • How understanding cultural backgrounds can lead to better patient care [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why developing new antibiotics is a losing battle
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...